4th International Conference on Epigenetics and Bioengineering (EpiBio)

第四届表观遗传学和生物工程国际会议(EpiBio)将于2020年10月9日至11日在虚拟平台上举行。这次会议将聚集生物学家、化学家和工程师，讨论他们的学科如何合作，为限制表观遗传建模发展的问题找到新的解决方案。EpiBio 2020将专注于将学术界和产业界的专业人士联系起来，目的是分享该领域新发现的基础知识，以及最终可用于为各种疾病创造有效的、个性化的治疗方法的新技术。EpiBio 2020大会将侧重于生化系统的发现，以及强调生物工程和工程医疗。这项科学计划将涉及六个主题，以单轨形式在两天内提交。检测表观遗传修饰将集中在检测甲基化和组蛋白修饰方面的新进展。编写表观遗传修饰的重点将是编写表观遗传修饰和相关工具集。核组织将专注于扩大表观遗传修饰的知识，并开发有效治疗疾病的方法。单细胞表观遗传学将集中在单细胞水平上表观遗传学的研究进展。新兴技术将专注于乙酰酶、DNA连接酶、甲基转移酶、RNA连接酶、逆转录酶和其他可用于进行实验性表观遗传修饰的技术。人类健康与疾病中的表观遗传学将解决表观遗传修饰如何导致疾病，以及如何利用生物工程工具开发新的治疗方法。同行评议的会议记录将发布在AIChE网站上，《国际分子科学杂志》可能会发布一期围绕会议主题的特刊。这一奖项反映了NSF的法定使命，并通过使用基金会的学术价值和更广泛的影响审查标准进行评估，被认为值得支持。

The 4th International Conference on Epigenetics and Bioengineering (EpiBio), will be held on October 9-11, 2020 on a virtual platform. This conference will bring together biologists, chemists, and engineers to discuss ways in which their disciplines can collaborate to find novel solutions to problems that are limiting the development of epigenetic modeling. EpiBio 2020 will focus on connecting professionals from academia and industry for the purpose of sharing newly uncovered fundamental knowledge in the field, as well as novel technologies that can ultimately be used to create effective, personalized treatments for a variety of diseases.The EpiBio 2020 conference will focus on discoveries in biochemical systems, as well as emphasize bioengineering and engineering healthcare. The scientific program will address six topics, presented over two days in a single-track format. Sensing Epigenetic Modifications will focus on new advances in sensing of methylation and histone modification. Writing Epigenetic Modifications will focus on writing epigenetic modifications and the relevant toolset. Nuclear Organization will focus on expanding knowledge of epigenetic modifications and developing methods of treating diseases effectively. Single Cell Epigenetics will focus on developments in the study of epigenetics at the single-cell level. Emerging Technologies will focus on technologies such as acetylases, DNA ligases, methyltransferase, RNA ligases, reverse transcriptase, and others that can be used to make experimental epigenetic modifications. Epigenetics in Human Health & Disease will address how epigenetic modifications can lead to disease and how bioengineering tools can be utilized to develop novel therapeutics. Peer-reviewed conference proceedings will be published on the AIChE website, and the International Journal of Molecular Sciences may publish a special issue around the themes of the conference.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.